Following on from last week’s Spending Review announcement, Community Pharmacy England has joined forces with other national primary care bodies to reiterate our call on Government to prioritise DHSC spending allocations towards primary care. The joint statement, copied below, has been signed by Community Pharmacy England, the General Practitioner’s Committee England, the British Dental Association’s
Read moreThe Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens Levemir® Penfill® 100units/ml solution for injection 3ml cartridges MSN/2025/036 Tier 2 – medium impact Date of issue: 16/06/2025 Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Venlafaxine 37.5mg modified-release tablets. MSN/2025/035 Tier 2 – medium impact Date of issue: 13th June 2025 Venlafaxine 37.5mg modified release (MR) tablets are out of stock until mid-July 2025. Venlafaxine 37.5mg MR capsules remain available and can support increased demand. Venlafaxine
Read moreWith the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across Yorkshire and the Humber and the North East are invited to ‘Future of
Read more
MHRA Class 2 Medicines Notification: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) Drug alert number: EL(25)A/27 Date issued: 12 June 2025 Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton.
Read morePharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering codes and list prices. Branded Product Name Generic Product Name Generic
Read moreThe Government’s Spending Review has concluded, with Chancellor Rachel Reeves today announcing the Government’s new spending priorities. The announcement included a 3% real terms uplift to NHS funding, for each of the coming three years, with the Government reiterating its commitment to its three shifts for healthcare: moving care closer to home, from treatment to
Read moreMHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states
Read moreMHRA Class 2 Medicines Notification: Paracetamol 500mg Tablets (Chelonia Healthcare Limited) Drug alert number: EL(25)A/25 Date issued: 09 June 2025 Chelonia Healthcare Limited is recalling specific batches of Paracetamol 500mg Tablets (100 pots) as a precautionary measure due to contamination following a small number of complaints of discoloured tablets within the pots. DMRC reference number:
Read moreNHS England has announced the launch of a new community pharmacy Point of Care (PoC) IT Supplier Contractual Framework, which will allow pharmacy owners to choose which PoC system they use to make their clinical records for the Flu and COVID-19 vaccination services during the Autumn/Winter 2025/26 campaign. IT suppliers listed on the new framework
Read more
